Teruo Miyazawa Selected Research

1-Deoxynojirimycin (1 Deoxynojirimycin)

1/2019	Physiological Effects and Organ Distribution of Bacillus amyloliquefaciens AS385 Culture Broth Powder Containing 1-Deoxynojirimycin in C57BL/6J Mice.
7/2017	Intake of mulberry 1-deoxynojirimycin prevents colorectal cancer in mice.
8/2013	Intake of mulberry 1-deoxynojirimycin prevents diet-induced obesity through increases in adiponectin in mice.
5/2013	Production of the α-glycosidase inhibitor 1-deoxynojirimycin from Bacillus species.
10/2012	A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect.
12/2009	Optimization of 1-deoxynojirimycin extraction from mulberry leaves by using response surface methodology.
7/2007	Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Teruo Miyazawa Research Topics

Disease

30	Neoplasms (Cancer) 01/2019 - 07/2003
10	Body Weight (Weight, Body) 01/2020 - 12/2002
10	Adenocarcinoma 01/2016 - 01/2004
9	Atherosclerosis 12/2019 - 01/2005
8	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 12/2008
6	Inflammation (Inflammations) 09/2021 - 06/2010
6	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2002
5	Colonic Neoplasms (Colon Cancer) 03/2022 - 01/2004
5	Aberrant Crypt Foci 03/2022 - 01/2019
5	Obesity 01/2020 - 08/2013
5	Hepatocellular Carcinoma (Hepatoma) 10/2016 - 05/2012
4	Dementia (Dementias) 01/2018 - 10/2008
4	Diabetes Mellitus 10/2012 - 07/2007
4	Infections 01/2010 - 08/2003
3	Diabetes Complications 07/2012 - 08/2010
3	Vascular Diseases (Vascular Disease) 06/2005 - 12/2002
2	Colitis 11/2021 - 07/2017
2	Hyperphagia (Overeating) 01/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 12/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2017 - 02/2016
2	Breast Neoplasms (Breast Cancer) 10/2014 - 01/2004
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2014 - 07/2012
2	Hyperglycemia 10/2011 - 08/2011
2	Hyperplasia 08/2010 - 06/2010
2	Mycoses (Diseases, Fungus) 09/2009 - 08/2003
2	Weight Loss (Weight Reduction) 08/2006 - 11/2005
1	Cognitive Dysfunction 08/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2021
1	Birth Weight (Birth Weights) 01/2021
1	Carcinogenesis 01/2021

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 03/2022 - 11/2005
12	TocotrienolsIBA 10/2016 - 07/2003
11	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017 - 02/2005
9	phosphatidylcholine hydroperoxideIBA 03/2015 - 04/2002
8	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2018 - 01/2004
7	1-Deoxynojirimycin (1 Deoxynojirimycin)IBA 01/2019 - 07/2007
5	Vitamin E FDA LinkGeneric 08/2015 - 11/2008
5	Proteins (Proteins, Gene)FDA Link 04/2012 - 01/2004
5	Eicosapentaenoic AcidIBA 03/2007 - 08/2003
4	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 03/2022 - 01/2019
4	Dimenhydrinate (DMH)FDA LinkGeneric 03/2022 - 01/2019
4	Ethanolamine (Colamine)IBA 11/2021 - 02/2016
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 08/2011
4	Blood Glucose (Blood Sugar)IBA 12/2019 - 07/2007
4	N- (1,6- dideoxyfructopyranosyl)- 1,3- dioleoyl- 2- phosphatidylethanolamineIBA 07/2012 - 12/2003
4	Docosahexaenoic AcidsIBA 12/2008 - 08/2003
4	CholesterolIBA 08/2006 - 03/2004
3	phosphatidal ethanolaminesIBA 11/2021 - 01/2016
3	vinyl ether (divinyl ether)IBA 11/2021 - 01/2021
3	Glycerophospholipids (Phosphoglycerides)IBA 11/2021 - 02/2016
3	Ethanol (Ethyl Alcohol)IBA 09/2021 - 01/2013
3	EnzymesIBA 01/2021 - 08/2005
3	AntioxidantsIBA 02/2018 - 11/2009
3	Messenger RNA (mRNA)IBA 07/2017 - 11/2008
3	ferulic acid (sodium ferulate)IBA 09/2016 - 10/2014
3	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2016 - 05/2009
3	Glycoside Hydrolases (Endoglycosidases)IBA 05/2013 - 12/2009
3	Triglycerides (Triacylglycerol)IBA 01/2013 - 08/2006
3	phosphatidylethanolamineIBA 07/2012 - 08/2010
3	Tocopherols (Tocopherol)IBA 06/2010 - 02/2007
3	delta tocotrienolIBA 06/2010 - 09/2006
2	Glucosylceramides (Glucocerebrosides)IBA 03/2022 - 09/2021
2	Carotenoids (Carotene)IBA 08/2021 - 06/2011
2	SqualeneIBA 12/2019 - 01/2019
2	GlucosidasesIBA 01/2019 - 07/2007
2	sesaminIBA 02/2018 - 09/2016
2	astaxanthine (astaxanthin)IBA 02/2018 - 06/2011
2	InterleukinsIBA 01/2018 - 09/2009
2	CurcuminIBA 01/2018 - 05/2014
2	InterferonsIBA 01/2018 - 09/2009
2	PolyphenolsIBA 09/2016 - 01/2013
2	Oleic Acid (Oleate)IBA 05/2016 - 05/2012
2	Caspase 3 (Caspase-3)IBA 02/2016 - 08/2015
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016 - 01/2013
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 12/2008
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 04/2012
2	Picryl Chloride (Trinitrochlorobenzene)IBA 01/2013 - 03/2012
2	Streptozocin (Streptozotocin)FDA Link 04/2012 - 10/2011
2	Advanced Glycation End ProductsIBA 04/2012 - 01/2005
2	LuteinIBA 01/2012 - 11/2009
2	alpha-Tocopherol FDA Link 06/2010 - 09/2006
2	Angiogenesis InhibitorsIBA 02/2009 - 11/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2009 - 08/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2008 - 08/2008
2	FructoseIBA 09/2006 - 01/2005
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2005 - 01/2004
2	PoisonsIBA 08/2005 - 03/2005
2	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2005 - 08/2004
1	AlkaliesIBA 03/2022
1	Dextran SulfateIBA 11/2021
1	SphingolipidsIBA 09/2021
1	VitaminsIBA 08/2021
1	Amino Acids, Peptides, and ProteinsIBA 08/2021
1	LeptinIBA 01/2020

Therapy/Procedure

7	Therapeutics 09/2016 - 08/2007
4	Oral Administration 05/2019 - 11/2009
2	Caloric Restriction 01/2018 - 07/2017
2	Glycemic Control 04/2012 - 04/2002